Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN)

Q: What does CUSIP 25056L103 represent in this 13F holders report?

CUSIP 25056L103 is the security identifier for DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q3 2022?

76 institutional investors reported DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q3 2022. Use the holders table for investor-level position and value details.

CUSIP: 25056L103

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 61,880,773
Total 13F shares: 39,933,593
Share change: +1,216,475
Total reported value: $667,698,632
Put/Call ratio: 16%
Reported price per share: $16.72
Number of holders: 76
Value change: +$24,544,231
Number of buys: 45
Number of sells: 28

Security key

25056L103

Report period

Q3 2022

Institutions

Top holders

DSGN full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2022 Previous quarter: Q2 2022 Design Therapeutics, Inc. SEC filings Design Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 25056L103

Newer quarter: Q4 2022 Previous quarter: Q2 2022

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

SR ONE CAPITAL MANAGEMENT...

13D/G signal

—

Evidence rows

Latest as of

30 Jun 2022

13F Lead comparable stake: 9.1% Showing 1-6 of 15 holder rows.

Rank 1 holder

SR ONE CAPITAL MANAGEMENT, LP

13F

Ownership: 9.1%
Position: $78.77M

13F

Rank 2 holder

Cormorant Asset Management, LP

13F

Ownership: 8.9%
Position: $77M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SR ONE CAPITAL MANAGEMENT, LP	13F Company 13F	9.1%	$78,771,000 5,626,476 shares	—	30 Jun 2022
Cormorant Asset Management, LP	13F Company 13F	8.9%	$77,000,000 5,500,000 shares	—	30 Jun 2022
BlackRock Finance, Inc.	13F Company 13F	5.7%	$49,559,000 3,539,936 shares	—	30 Jun 2022
Logos Global Management LP	13F Company 13F	4.5%	$39,165,000 2,797,501 shares	—	30 Jun 2022
EcoR1 Capital, LLC	13F Company 13F	4.3%	$36,878,000 2,634,178 shares	—	30 Jun 2022
CITADEL ADVISORS LLC	13F Company 13F	4.1%	$35,639,000 2,545,658 shares	—	30 Jun 2022

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

39,933,593

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend